Alaxia is a leading French biotech firm founded in 2008, dedicated to pioneering therapeutic advancements in respiratory health through its innovative antimicrobial solutions. The company specializes in creating therapeutic solutions for respiratory illnesses with a focus on cystic fibrosis using its unique peroxidase platform. Their flagship drug candidate, ALX-009, is designed to target even the most resilient bacterial strains associated with cystic fibrosis, offering a promising treatment option for this challenging condition.
Alaxia
Pioneering therapeutic advancements in respiratory health with an innovative antimicrobial solution targeting cystic fibrosis.
Founded 2008
Biotechnology
Get notified when Alaxia moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Alaxia
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
Biotechnology
About Alaxia
Taxonomy: biotech firm, respiratory health, therapeutic advancements, cystic fibrosis, antimicrobial solution, peroxidase platform, drug candidate, innovative compound, French biotech, private company, respiratory diseases, bacterial strains, therapeutic solutions, resilient bacteria, ALX-009
No funding data available for Alaxia yet.
Get notified when Alaxia raises fundingAlaxia Alternatives & Competitors
Alaxia vs
A clinical-stage biotech company focusing on discovering, developing and commercializing inhalation...
Series C
3 employees
Biotechnology, Health Care
Alaxia vs
KlinEra Global Services
United States
Customized Services, Global Reach.
176 employees
Health Care, Pharmaceutical
Alaxia vs
Advaccine
China
Advancing Vaccines，Improving Immunotherapeutics
Private Equity
5 employees
Biopharma, Biotechnology
FAQ About Alaxia
Pioneering therapeutic advancements in respiratory health with an innovative antimicrobial solution targeting cystic fibrosis.
Alaxia was founded in 2008.
Alaxia operates in the following industries: Biotechnology.
Top alternatives and competitors to Alaxia include Chance Pharmaceuticals 畅溪制药, KlinEra Global Services, Advaccine, InhalPlus, Inspira Pharmaceuticals Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Alaxia and Chance Pharmaceuticals 畅溪制药 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Alaxia and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.